MORTIMER IAN

CIK 00016199611 companyBURNABY, A1

SEC Profile

Transactions

Companies

Filings

CIK

0001619961

Recent Transactions

50 trades

Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2026-03-13$55.23/sh−7,308→ 19,923 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Restricted Share Units
2026-03-12−12,500→ 37,500 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2026-03-12+12,500→ 27,231 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2026-03-10$60.11/sh−11,269→ 14,731 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option
2026-03-09−105,000→ 0 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option
2026-03-09−25,000→ 0 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option
2026-03-09−75,000→ 0 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2026-03-09+20,000→ 26,000 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2026-03-09$62.06/sh−65,000→ 6,000 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2026-03-09$9.44/sh+65,000→ 71,000 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2026-03-09$60.08/sh−61,652→ 6,000 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2026-03-09$59.26/sh−43,348→ 72,652 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2026-03-09$4.75/sh+105,000→ 111,000 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2026-03-09$61.26/sh−2,449→ 6,000 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2026-03-09$60.47/sh−10,072→ 8,449 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2026-03-09$59.88/sh−31,694→ 27,515 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Performance Share Units
2026-03-09−20,000→ 0 total
Award
Xenon Pharmaceuticals Inc.$XENE
Performance Share Units
2026-03-09+20,000→ 20,000 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option
2026-03-09−65,000→ 0 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2026-03-09$60.49/sh−21,515→ 6,000 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2026-03-09$58.81/sh−21,791→ 59,209 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2026-03-09$8.40/sh+75,000→ 81,000 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2026-03-09$59.50/sh−12,479→ 18,521 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2026-03-09$3.10/sh+25,000→ 31,000 total
Award
Xenon Pharmaceuticals Inc.$XENE
Share Option (Right to Buy)
2026-01-09+350,000→ 350,000 total
Award
Xenon Pharmaceuticals Inc.$XENE
Restricted Share Units
2026-01-09+65,000→ 65,000 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2026-01-02$44.40/sh−37,938→ 8,062 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2026-01-02−40,000→ 0 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2026-01-02$44.93/sh−2,062→ 6,000 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2026-01-02$7.49/sh+40,000→ 46,000 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2025-12-08$46.32/sh−2,010→ 6,000 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2025-12-08$45.59/sh−8,820→ 8,010 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2025-12-05$45.03/sh−14,375→ 16,830 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2025-11-28$45.01/sh−97→ 31,205 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2025-10-01$7.69/sh+25,000→ 56,302 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2025-10-01$40.16/sh−25,000→ 31,302 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2025-10-01−25,000→ 0 total
Award
Xenon Pharmaceuticals Inc.$XENE
Share Option (Right to Buy)
2025-03-12+275,000→ 275,000 total
Award
Xenon Pharmaceuticals Inc.$XENE
Restricted Share Units
2025-03-12+50,000→ 50,000 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2025-01-27−16,315→ 0 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2025-01-27$41.07/sh−1,149→ 31,302 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2025-01-27$17.76/sh+1,149→ 32,451 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2025-01-27$17.76/sh+15,166→ 46,468 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2025-01-27$40.46/sh−15,166→ 31,302 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2025-01-24−22,468→ 16,315 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2025-01-24$17.76/sh+22,468→ 53,770 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2025-01-24$40.20/sh−22,468→ 31,302 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2025-01-23$40.08/sh−16,217→ 31,302 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2025-01-23$17.76/sh+16,217→ 47,519 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2025-01-23−16,217→ 38,783 total

Companies

Xenon Pharmaceuticals Inc.
Director, PRESIDENT & CEO
$XENE

Recent Filings

Address

3650 GILMORE WAY

BURNABY, A1, V5G 4W8

View on SEC.gov